248 related articles for article (PubMed ID: 32945604)
1. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review.
Pezzuto A; D'Ascanio M; Ricci A; Pagliuca A; Carico E
Thorac Cancer; 2020 Nov; 11(11):3060-3070. PubMed ID: 32945604
[TBL] [Abstract][Full Text] [Related]
2. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
[TBL] [Abstract][Full Text] [Related]
3. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
4. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.
Vonlanthen S; Heighway J; Altermatt HJ; Gugger M; Kappeler A; Borner MM; van Lohuizen M; Betticher DC
Br J Cancer; 2001 May; 84(10):1372-6. PubMed ID: 11355949
[TBL] [Abstract][Full Text] [Related]
5. Ectopic p16(ink4) expression enhances CPT-11-induced apoptosis through increased delay in S-phase progression in human non-small-cell-lung-cancer cells.
Fukuoka K; Nishio K; Fukumoto H; Arioka H; Kurokawa H; Ishida T; Iwamoto Y; Tomonari A; Suzuki T; Usuda J; Narita N; Saijo N
Int J Cancer; 2000 Apr; 86(2):197-203. PubMed ID: 10738246
[TBL] [Abstract][Full Text] [Related]
6. [The Relationship of Clinicopathology of p16 in Non-small Cell Lung Cancer and 5-nitrogen impurity-2'-deoxycytidine-nitrogen Impurity on the Influence of p16 Expression in Lung Cancer A549 Cells].
Hua CS; Ma DC; Chen H; Zhang CD; Wang WS; Ding X; Zhao J; Wu F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):404-407. PubMed ID: 30014643
[TBL] [Abstract][Full Text] [Related]
7. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
8. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
[TBL] [Abstract][Full Text] [Related]
9. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
[TBL] [Abstract][Full Text] [Related]
10. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
[TBL] [Abstract][Full Text] [Related]
11. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
[TBL] [Abstract][Full Text] [Related]
12. p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis.
Kawabuchi B; Moriyama S; Hironaka M; Fujii T; Koike M; Moriyama H; Nishimura Y; Mizuno S; Fukayama M
Int J Cancer; 1999 Feb; 84(1):49-53. PubMed ID: 9988232
[TBL] [Abstract][Full Text] [Related]
13. Independent prognostic role of p16 expression in lung cancer.
Groeger AM; Caputi M; Esposito V; De Luca A; Bagella L; Pacilio C; Klepetko W; Giordano GG; Baldi F; Kaiser HE; Wolner E; Giordano A
J Thorac Cardiovasc Surg; 1999 Sep; 118(3):529-35. PubMed ID: 10469971
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
15. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
Kawamata N; Miller CW; Koeffler HP
Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
[TBL] [Abstract][Full Text] [Related]
17. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
18. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
Brambilla E; Gazzeri S; Moro D; Lantuejoul S; Veyrenc S; Brambilla C
Clin Cancer Res; 1999 Feb; 5(2):243-50. PubMed ID: 10037171
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
20. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
